QS/1 integrates with Appriss Health’s NARxCHECK
QS/1 said it’s the first pharmacy management software provider to integrate partner with Appriss Health’s NARxCHECK into a pharmacy’s workflow.
Supplier News
New store showcases L’Oréal’s NYX Cosmetics
NYX Cosmetics has opened its 20th store, a 2,000-square-foot flagship in Manhattan’s bustling Union Square area. Although the L’Oréal-owned brand has several sites in nearby New Jersey, this was its first in New York City. It is the largest to date, with more than 2,000 SKUs.
Arete Pharmacy Network acquires PSAO RxPride
Arete Pharmacy Network LLC has acquired RxPride LLC, a pharmacy services administrative organization (PSAO) formerly owned by Smart-Fill Management Group Inc.
WUNDERBROW eyebrow gel to hit shelves at CVS
KF Beauty has landed retail distribution for its WUNDERBROW eyebrow gel at CVS Pharmacy. The company said WUNDERBROW, part of its WUNDER2 beauty care line, will be sold in more than 500 CVS drug stores nationwide as well as online at CVS.com.
Coca-Cola names Quincey to succeed Kent as CEO
Muhtar Kent is stepping down as chief executive officer of Coca-Cola Co. and will be succeeded by James Quincey, president and chief operating officer. Coca-Cola said Friday that plans call for Quincey to take the CEO reins from Kent on May 1.
Sandoz releases generic version of Latisse
Sandoz Inc. has introduced bimatoprost ophthalmic solution 0.03%, an eyelash treatment, in the U.S. market. The Novartis subsidiary said its bimatoprost ophthalmic product is a generic version of Latisse from Allergan. A prescription medicine, bimatoprost ophthalmic solution 0.
Curve for Men social campaign aimed at Gen Z
Fragrance brand Curve for Men has launched a 360-degree integrated marketing campaign dubbed #CurveYourReality. Curve Fragrances said Wednesday that the campaign targets Generation Z consumers and focuses on bringing “personality, individualism and personalization” to the brand.
Teva announces CEO succession for generics group
Dipankar Bhattacharjee has been promoted to president and chief executive officer of the Global Generic Medicines Group at Teva Pharmaceutical Industries Ltd. The appointment is effective immediately.
Jardiance approved to cut cardiovascular death risk
Jardiance tablets, marketed by Boehringer Ingelheim and Eli Lilly and Co., have been approved by the Food and Drug Administration to cut the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
J M Smith to acquire Burlington Drug
J M Smith Corp. plans to acquire drug wholesaler Burlington Drug Co. and certain retail operations assets of Pharmacy Health Services (PHS). Financial terms of the transaction weren’t disclosed.
HDA: Pharmacy chains still drug distributors’ top customer
Chain drug stores remain the largest customer base for pharmaceutical distributors, according to the Healthcare Distribution Alliance (HDA). Drug chains accounted for 42.
VoicePort teams up with iMedicare
VoicePort LLC has partnered with iMedicare to provide patient-specific Medicare plan analyses to community pharmacists via the VoicePort CLARO adherence application.
General Mills realigns global organization
General Mills has unveiled a new global organizational structure that eliminates a key international post and will result in hundreds of job cuts. The food company said Monday that it’s dropping the position of international chief operating officer.
Identigene acquired by DNA Diagnostics Center
DNA Diagnostics Center (DDC) has acquired at-home paternity test provider Identigene LLC. Financial terms of the transaction weren’t disclosed.
Akers Bio cholesterol test to get First Check branding
Akers Biosciences Inc. has entered an agreement with First Check Diagnostics LLC to exclusively distribute its rapid cholesterol self-test in the United States under the First Check brand.
McKesson to launch Central Fill as a Service
McKesson Corp.’s High Volume Solutions group is set to roll out Central Fill as a Service (CFaaS), a solution that gives pharmacies central-fill capability without the investment in equipment, inventory and extra staff.